Latest Trials Latest NewsFAQ

M.D. ANDERSON CANCER CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Use of Water Warming/Cooling Garment to Maintain a Constant Intraoperative Core Target Temperature in Patients Undergoing Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Proof-of-Concept Study

Early Phase 1

Withdrawn

Conditions: Hyperthermic Intraperitoneal

Interventions: Device: Allon System

First Posted Date: 2022-07-26

Last Posted Date: 2023-05-06

Lead Sponsor: M.D. Anderson Cancer Center

Registration Number: NCT05474352

Locations: 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States

Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION)

Phase 2

Recruiting

Conditions: Cervical Cancer
Metastatic Cancer

Interventions: Drug: Lorigerlimab

First Posted Date: 2022-07-26

Last Posted Date: 2024-12-17

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 40

Registration Number: NCT05475171

Locations: 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States

Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic Melanoma

Phase 1

Active, not recruiting

Conditions: Tumor
Melanoma
Metastatic Melanoma

Interventions: Drug: OBX-115
Drug: Acetazolamide
Drug: Cyclophosphamide
Drug: Furosemide
Drug: Mesna
Drug: Fludarabine Phosphate

First Posted Date: 2022-07-22

Last Posted Date: 2024-10-09

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 21

Registration Number: NCT05470283

Locations: 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States

A Phase II Randomized Controlled Trial to Determine the Efficacy of an auGmented reAlity gaMe in pediatrIc caNcer Patients Who Are Opioid Naïve Undergoing Surgery to Reduce Postoperative Opioid Use (GAMING-ON Study)

Phase 2

Active, not recruiting

Conditions: Cancer
Pediatric ALL

Interventions: Other: IPAD
Other: Augmented Reality

First Posted Date: 2022-07-20

Last Posted Date: 2024-10-02

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 29

Registration Number: NCT05466994

Locations: 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
🇺🇸
Texas Children's Hospital, Houston, Texas, United States

Phase II Study to Evaluate Safety and Efficacy of CB-103 With Venetoclax in Adolescent and Young Adult Patients With Relapsed/Refractory T-ALL or T-LBL

Phase 2

Terminated

Conditions: Leukemia, Lymphoblastic
Leukemia

Interventions: Drug: CB-103
Drug: Venetoclax

First Posted Date: 2022-07-19

Last Posted Date: 2024-08-19

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 2

Registration Number: NCT05464836

Locations: 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States

Feasibility of Combined Genomics/Transcriptomics for Patients With Lymphoma

Not Applicable

Recruiting

Conditions: Lymphoma

Interventions: Other: Molecular Functional Portrait

First Posted Date: 2022-07-19

Last Posted Date: 2024-08-16

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 80

Registration Number: NCT05464823

Locations: 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States

A Phase II Study of Loncastuximab Tesirine as Consolidation Strategy in Patients With LBCL in PR After CAR T-cell Therapy

Phase 2

Recruiting

Conditions: Lymphoma
Large B-cell Lymphoma

Interventions: Drug: Loncastuximab Tesirine

First Posted Date: 2022-07-19

Last Posted Date: 2024-12-18

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 30

Registration Number: NCT05464719

Locations: 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States

Implementation of Digital Vital Sign Monitoring to Decrease Sleep Interruption and Enhance Recovery in Phase II of the PROmoting Sleep, Patient Engagement and Recovery (PROSPER) Project

Phase 2

Terminated

Conditions: Sleep

Interventions: Device: ViSi Mobile device
Drug: Sleep enhancement intervention

First Posted Date: 2022-07-13

Last Posted Date: 2024-12-18

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 89

Registration Number: NCT05456360

Locations: 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States

An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate Cancer

Phase 2

Recruiting

Conditions: Prostate Cancer

Interventions: Other: Focal Cryoablation
Other: Standard of Care
Other: Quality-of-life Questionnaires

First Posted Date: 2022-07-12

Last Posted Date: 2024-10-21

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 30

Registration Number: NCT05454488

Locations: 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States

Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers

Not Applicable

Recruiting

Conditions: Cancer
Aging
Communication

Interventions: Behavioral: Geriatric Assessment

First Posted Date: 2022-06-29

Last Posted Date: 2024-10-30

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 1500

Registration Number: NCT05436327

Locations: 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy